BioCentury | Oct 8, 2019
Company News

Oct. 8 Company Quick Takes: Novartis’ anti-VEGF approved for AMD; plus Merck-4D, Acorda, Clinuvel and Puma

...that invalidated on grounds of obviousness four patents covering a 10 mg dose of Ampyra dalfampridine...
BioCentury | Aug 2, 2019
Company News

Aug. 2 Company Quick Takes: Daiichi's cancer drug gets U.S. approval, plus BioMarin, Acorda, Stemline and more

...slower-than-expected uptake of newly launched Inbrija inhaled levodopa as revenues from multiple sclerosis drug Ampyra dalfampridine...
...Parkinson's disease. Acorda does not expect clarity on Inbrija's launch trajectory until late this year. Ampyra...
BioCentury | Jan 4, 2019
Clinical News

FDA approves Acorda's Inbrija for Parkinson's

...bring to market following the arrival of generic competition for its multiple sclerosis drug Ampyra dalfampridine...
...its value on Sept. 10, when a federal appeals court upheld a ruling that left Ampyra...
...protection against generic competition. Later that month, Mylan N.V. (NASDAQ:MYL) launched an authorized generic of Ampyra...
BioCentury | Dec 24, 2018
Company News

FDA approves Acorda's Inbrija for Parkinson's

...bring to market following the arrival of generic competition for its multiple sclerosis drug Ampyra dalfampridine...
...its value on Sept. 10, when a federal appeals court upheld a ruling that left Ampyra...
...protection against generic competition. Later that month, Mylan N.V. (NASDAQ:MYL) launched an authorized generic of Ampyra...
BioCentury | Sep 14, 2018
Company News

Acorda loses Amprya appeal, reports Inbrija PDUFA delay

...to $17.25 the week of Sept. 10 following setbacks related to multiple sclerosis drug Ampyra dalfampridine...
...Court of Appeals for the Federal Circuit upheld a 2017 district court ruling that leaves Ampyra...
...full-year 2018 Ampyra sales revenue to be $330-$350 million. The company has worldwide rights to Ampyra...
BioCentury | Sep 10, 2018
Company News

Acorda loses appeal to shield Ampyra from generic entry

...the Federal Circuit upheld a 2017 district court ruling that leaves multiple sclerosis drug Ampyra dalfampridine...
...After Court Invalidates Ampyra Patents" ). The fifth and last Orange Book-listed patent that protected Ampyra...
...full-year 2018 Ampyra sales revenue to be $330-$350 million. The company has worldwide rights to Ampyra...
BioCentury | Aug 10, 2018
Company News

Acorda, Mylan reach settlement for Ampyra generic

...NASDAQ:MYL) that would allow Mylan to market a generic version of multiple sclerosis drug Ampyra dalfampridine...
...of Appeals for the Federal Circuit denied the company's injunction to prevent generic competition for Ampyra...
...of a district court ruling is ongoing (see "Court of Appeals Denies Acorda's Injunction for Ampyra"...
BioCentury | Aug 6, 2018
Company News

Acorda, Mylan reach settlement for Ampyra generic

...NASDAQ:MYL) that would allow Mylan to market a generic version of multiple sclerosis drug Ampyra dalfampridine...
...of Appeals for the Federal Circuit denied the company's injunction to prevent generic competition for Ampyra...
...of a district court ruling is ongoing (see "Court of Appeals Denies Acorda's Injunction for Ampyra"...
BioCentury | Jul 27, 2018
Company News

Court of Appeals denies Acorda's injunction for Ampyra

...Appeals for the Federal Circuit denied the company's injunction to prevent generic competition for Ampyra dalfampridine...
...of Appeals does not overturn the lower court's ruling by July 30, generic versions of Ampyra...
...June 7 (see "Acorda Gains Following Ampyra Appeal Arguments" ). Acorda has worldwide rights to Ampyra...
BioCentury | Jul 25, 2018
Company News

Court of Appeals denies Acorda's injunction for Ampyra

...Appeals for the Federal Circuit denied the company's injunction to prevent generic competition for Ampyra dalfampridine...
...of Appeals does not overturn the lower court's ruling by July 30, generic versions of Ampyra...
...June 7 (see "Acorda Gains Following Ampyra Appeal Arguments" ). Acorda has worldwide rights to Ampyra...
Items per page:
1 - 10 of 328